湖北津药药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
141
NMPA:141
Drug Approvals
Naloxone Hydrochloride Injection
- Product Name
- 盐酸纳洛酮注射液
- Approval Number
- 国药准字H20253615
- Approval Date
- Mar 11, 2025
NMPA
Naloxone Hydrochloride Injection
- Product Name
- 盐酸纳洛酮注射液
- Approval Number
- 国药准字H20253614
- Approval Date
- Mar 11, 2025
NMPA
Potassium Chloride Injection
- Product Name
- 氯化钾注射液
- Approval Number
- 国药准字H20247289
- Approval Date
- Nov 20, 2024
NMPA
Bromhexine Hydrochloride Injection
- Product Name
- 盐酸溴己新注射液
- Approval Number
- 国药准字H20244991
- Approval Date
- Sep 26, 2024
NMPA
Phloroglucinol Injection
- Product Name
- 间苯三酚注射液
- Approval Number
- 国药准字H20244675
- Approval Date
- Aug 20, 2024
NMPA
Levofloxacin Hydrochloride Injection
- Product Name
- 盐酸左氧氟沙星注射液
- Approval Number
- 国药准字H20093706
- Approval Date
- May 24, 2024
NMPA
Levofloxacin Hydrochloride Injection
- Product Name
- 盐酸左氧氟沙星注射液
- Approval Number
- 国药准字H20093705
- Approval Date
- Apr 25, 2024
NMPA
Isosorbide Mononitrate Injection
- Product Name
- 单硝酸异山梨酯注射液
- Approval Number
- 国药准字H20093376
- Approval Date
- Mar 21, 2024
NMPA
Lidocaine Carbonate Injection
- Product Name
- 碳酸利多卡因注射液
- Approval Number
- 国药准字H20093195
- Approval Date
- Mar 21, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 15
- Next
Clinical Trials
No trials found
News
No news found